Barbara Degar

Barbara Degar, MD

Associate Director of Inpatient Oncology

Assistant Professor in Pediatrics

    Contact: 617-632-5286
  • Fax: 617-632-2270

Medical Services


  • Leukemia
  • Histiocytosis
  • Acute Myeloid Leukemia
  • Post Transplant Lymphoproliferative Disorder PTLD
  • Hematology Oncology


  • Hematology / Oncology
  • Medicine


  • Hematology / Oncology
  • Leukemia
To schedule an appointment: Call 617-632-5286 or Request an Appointment

Experience and Education


New York University School of Medicine, 1987-1991

New York, NY

Undergraduate School

Smith College, 1981-1985

Northampton, MA



Publications powered by Harvard Catalyst Profiles
  1. Koegel AK, Hofmann I, Moffitt K, Degar B, Duncan C, Tubman VN. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. Pediatr Blood Cancer. 2016 Oct; 63(10):1844-7.
  2. Ginat DT, Vargas SO, Silvera VM, Volk MS, Degar BA, Robson CD. Imaging Features of Juvenile Xanthogranuloma of the Pediatric Head and Neck. AJNR Am J Neuroradiol. 2016 May; 37(5):910-6.
  3. Degar B. Familial Hemophagocytic Lymphohistiocytosis. Hematol Oncol Clin North Am. 2015 Oct; 29(5):903-13.
  4. Chellapandian D, Shaikh F, van den Bos C, Somers GR, Astigarraga I, Jubran R, Degar B, Carret AS, Mandel K, Belletrutti M, Dix D, Visser J, Abuhadra N, Chang T, Rollins B, Whitlock J, Weitzman S, Abla O. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2162-6.
  5. Ribeiro KB, Degar B, Antoneli CB, Rollins B, Rodriguez-Galindo C. Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2015 Jun; 62(6):982-7.
  6. Sheu J, Saavedra AP, Degar BA, Duncan CN, Fawaz R, Tan JK, Schmidt BA, Kim HB, Huang JT. Bone marrow engraftment and associated dermatologic sequelae in a three-yr-old after liver transplantation. Pediatr Transplant. 2015 Mar; 19(2):E41-6.
  7. Karol SE, Coustan-Smith E, Cao X, Shurtleff SA, Raimondi SC, Choi JK, Ribeiro RC, Dahl GV, Bowman WP, Taub JW, Degar B, Leung W, Downing JR, Pui CH, Rubnitz JE, Campana D, Inaba H. Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy. Br J Haematol. 2015 Jan; 168(1):94-101.
  8. Walsh KE, Roblin DW, Weingart SN, Houlahan KE, Degar B, Billett A, Keuker C, Biggins C, Li J, Wasilewski K, Mazor KM. Medication errors in the home: a multisite study of children with cancer. Pediatrics. 2013 May; 131(5):e1405-14.
  9. Bates SV, Lakshmanan A, Green AL, Terry J, Badalian-Very G, Rollins BJ, Fleck P, Aslam M, Degar BA. BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate. AJP Rep. 2013 Oct; 3(2):63-6.
  10. Inaba H, Coustan-Smith E, Cao X, Pounds SB, Shurtleff SA, Wang KY, Raimondi SC, Onciu M, Jacobsen J, Ribeiro RC, Dahl GV, Bowman WP, Taub JW, Degar B, Leung W, Downing JR, Pui CH, Rubnitz JE, Campana D. Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. J Clin Oncol. 2012 Oct 10; 30(29):3625-32.
  11. Show all
  12. Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012 Jan; 156(2):163-72.
  13. Lindamood KE, Fleck P, Narla A, Vergilio JA, Degar BA, Baldwin M, Wintermark P. Neonatal enteroviral sepsis/meningoencephalitis and hemophagocytic lymphohistiocytosis: diagnostic challenges. Am J Perinatol. 2011 May; 28(5):337-46.
  14. Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010 Sep 16; 116(11):1919-23.
  15. Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, Pounds S, Razzouk BI, Lacayo NJ, Cao X, Meshinchi S, Degar B, Airewele G, Raimondi SC, Onciu M, Coustan-Smith E, Downing JR, Leung W, Pui CH, Campana D. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010 Jun; 11(6):543-52.
  16. Degar BA, Rollins BJ. Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one? Dis Model Mech. 2009 Sep-Oct; 2(9-10):436-9.
  17. Hazen MM, Woodward AL, Hofmann I, Degar BA, Grom A, Filipovich AH, Binstadt BA. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum. 2008 Feb; 58(2):567-70.
  18. Rodig SJ, Payne EG, Degar BA, Rollins B, Feldman AL, Jaffe ES, Androkites A, Silverman LB, Longtine JA, Kutok JL, Fleming MD, Aster JC. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol. 2008 Feb; 83(2):116-21.
  19. Degar, BA; Fleming, MD; Rollins, BJ. The Histiocytoses. Hematology of Infancy and Childhood (Orkin SH et al., eds.). 2008.
  20. Mullen, EA; Degar, BA. Oncology (Section Editor). Comprehensive Pediatric Hospital Medicine (Zaoutis and Chiang, eds.). 2007.
  21. Degar, BA; Isakoff, M . Childhood Cancer. Comprehensive Pediatric Hospital Medicine (Zaoutis and Chiang, eds.). 2007.
  22. Hait E, Liang M, Degar B, Glickman J, Fox VL. Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Pediatrics. 2006 Nov; 118(5):e1593-9.
  23. Zhang HZ, Degar BA, Rogoulina S, Resor C, Booth CJ, Sinning J, Gage PJ, Forget BG. Hematopoiesis following disruption of the Pitx2 homeodomain gene. Exp Hematol. 2006 Feb; 34(2):167-78.
  24. Wang S, Degar BA, Zieske A, Shafi NQ, Rose MG. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. Am J Hematol. 2004 Dec; 77(4):391-6.
  25. Rose MG, Degar BA, Berliner N. Molecular diagnostics of malignant disorders. Clin Adv Hematol Oncol. 2004 Oct; 2(10):650-60.
  26. Rose, MG; Degar, BA; Berliner, N. Molecular Diagnostics of Malignant Disorders. Clin Advances in Hematology/Oncology. 2004; 2(10):650-660.
  27. K Stegmaier, B Degar. Molecular Basis of Hematology. 2004.
  28. N Berliner, B Degar. Molecular Basis of Hematology. 2003.
  29. Degar, BA; Berliner, N . Introduction to the Lymphoproliferative Disorders. Oxford Textbook of Medicine, E.J. Benz (ed). 2003.
  30. Degar BA, Baskaran N, Hulspas R, Quesenberry PJ, Weissman SM, Forget BG. The homeodomain gene Pitx2 is expressed in primitive hematopoietic stem/progenitor cells but not in their differentiated progeny. Exp Hematol. 2001 Jul; 29(7):894-902.
  31. Forget, BG ; Degar, BA; Arcasoy, MO. Familial Polycythemia Due to Truncations of the Erythropoietin Receptor. Transactions of the American Clinical and Climatological Association. 2000; 11:38-45.
  32. Degar BA, Harrington RD, Rappeport JM, Woolfrey AE. 13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma. Med Pediatr Oncol. 1999 Apr; 32(4):308-10.
  33. Arcasoy MO, Degar BA, Harris KW, Forget BG. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood. 1997 Jun 15; 89(12):4628-35.
  34. Silber R, Degar B, Costin D, Newcomb EW, Mani M, Rosenberg CR, Morse L, Drygas JC, Canellakis ZN, Potmesil M. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood. 1994 Nov 15; 84(10):3440-6.
To schedule an appointment: Call 617-632-5286 or Request an Appointment


Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337